Physiological cardiac hypertrophy, in response to stimuli such as exercise, is considered adaptive and beneficial. In contrast, pathological cardiac hypertrophy that arises in response to pathological stimuli such as unrestrained high blood pressure and oxidative or metabolic stress is maladaptive and may precede heart failure. We found that the transcript encoding DNA damage-inducible transcript 4-like (DDiT4L) was expressed in murine models of pathological cardiac hypertrophy but not in those of physiological cardiac hypertrophy. In cardiomyocytes, DDiT4L localized to early endosomes and promoted stress-induced autophagy through a process involving mechanistic target of rapamycin complex 1 (mTORC1). Exposing cardiomyocytes to various types of pathological stress increased the abundance of DDiT4L, which inhibited mTORC1 but activated mTORC2 signaling. Mice with conditional cardiac-specific overexpression of DDiT4L had mild systolic dysfunction, increased baseline autophagy, reduced mTORC1 activity, and increased mTORC2 activity, all of which were reversed by suppression of transgene expression. Genetic suppression of autophagy also reversed cardiac dysfunction in these mice. Our data showed that DDiT4L may be an important transducer of pathological stress to autophagy through mTOR signaling in the heart and that DDiT4L could be therapeutically targeted in cardiovascular diseases in which autophagy and mTOR signaling play a major role.
INTRODUCTION
Autophagy is a critical, highly orchestrated, cellular catabolic process that plays a vital role in cell homeostasis and adaptation to stress in the heart. Consequently, dysregulation of autophagy leads to cell damage and death. Autophagy has multiple roles in cardiac diseases and is altered at different points in many cardiac diseases (1) . Furthermore, autophagy can be either protective or detrimental in cardiac disease (2) . Because of the importance of autophagy in the heart, insights into its regulation would answer an unmet need in the field and potentially identify therapeutic targets for cardiovascular diseases.
An important regulator of autophagy is the mechanistic target of rapamycin (mTOR), which responds to various stimuli such as growth factors, cellular energy status, oxygen concentrations, and stress to control cell metabolism and growth (3) . mTOR acts in two distinct complexes: the rapamycin-sensitive mTOR complex 1 (mTORC1) consisting of mTOR, raptor, and mLST8, which enhances protein synthesis and cell growth but inhibits autophagy, and the rapamycin-insensitive complex mTORC2 consisting of mTOR, rictor, sin1, and mLST8, which is implicated in cell proliferation, cell growth, and cytoskeleton rearrangement (4) . Like autophagy, mTOR has a complex role in the heart, and its dysregulation has been implicated in many types of heart disease (5) (6) (7) (8) (9) (10) (11) .
DDiT4L (DNA damage-inducible transcript 4-like; also known as Redd2 and Rtp801L) and its homolog DDiT4 are upstream inhibitors of mTOR in several tissues and cell models (12) (13) (14) (15) . Here, using Deep Serial Analysis of Gene Expression (DSAGE), we identified DDiT4L as a candidate gene with the greatest increase in expression in a murine model of pathological hypertrophy but not in one of physiological hypertrophy. We showed that DDiT4L was expressed in cardiomyocytes and was increased in murine and cultured neonatal rat ventricular myocyte (NRVM) models of pathological but not physiological stress and in cardiac tissue from patients with dilated cardiomyopathy (DCM). Notably, the abundance of the related DDiT4 was not changed by pathological stress. DDiT4L was transcriptionally controlled by serum response factor (SRF), localized in early endosomes, and was itself a key regulator of stress-induced (but not baseline) autophagy through mTORC1 inhibition in NRVMs. Adult mice with conditional cardiacspecific overexpression of DDiT4L had increased autophagy, repressed mTORC1 signaling, and decreased left ventricular wall thickness with mild left ventricular dilation. This phenotype was fully reversed by suppression of transgene expression and relied on autophagy because it was also reversed by genetic suppression of autophagy (which was achieved by breeding DDiT4L transgenic mice to beclin 1 haploinsufficient mice). Finally, DDiT4L also activated mTORC2 signaling. In summary, we showed that DDiT4L promoted autophagy by inhibiting mTOR signaling and that its abundance was increased in response to pathological stressors downstream of SRF in a manner distinct from the related DDiT4. Our results also suggested that an increase in stress-induced autophagy at baseline (in the absence of stress) may lead to cardiac structural changes and mild dysfunction that can be reversed by cessation of autophagy without adverse effects.
RESULTS
DDiT4L gene expression is increased with pathological but not physiological stress To identify genes that are differentially altered in pathological cardiac hypertrophy and physiological hypertrophy, we used DSAGE, a nanotechnology that facilitates global transcriptional profiling (16) . We compared transcriptional profiles from hearts of transgenic mice with cardiac overexpression of constitutively active serum and glucocorticoidregulated kinase-1 (SGK1-CA), a model for pathological hypertrophy (17) ; constitutively active Akt1 (Akt1-CA), a model of physiological or adaptive hypertrophy (18) ; and their relative controls [dominant negative (DN) SGK1 or Akt1] (19) and wild-type littermates. Cardiac tissue from 4-week-old mice (before cardiac dysfunction developed in the SGK1-CA mice) was used for the experiments. Complementary DNA (cDNA;~2 × 10 6 ) clones from each genotype were sequenced, corresponding to >33,000 independent transcripts (data file S1). DDiT4L was the transcript with the greatest increase in expression in SGK1-CA mice compared to wild-type mice ( Fig. 1A and table S1), and its abundance did not significantly change in any of the other genotypes (table S1). The expression of DDiT4, the closest homolog to DDiT4L, decreased in the SGK1-CA pathological hypertrophy model and did not change in the Akt1-CA physiological hypertrophy model (table S1) . Quantitative polymerase chain reaction (qPCR) analysis confirmed that the expression of DDiT4L, but not DDiT4, was increased both in SGK1-CA hearts and in NRVMs with adenoviral overexpression of SGK1-CA (Fig. 1, B and C, and fig. S1 , A and B). DDiT4L expression was not changed in NRVMs with adenoviral overexpression of myr-Akt1 (Fig. 1C) .
To investigate whether DDIT4L is increased in other models of hypertrophy and heart failure, we measured DDiT4L in a genetic model of DCM caused by an F764L missense mutation in the gene encoding myosin heavy chain (MHC) (20) , the transverse aortic constriction (TAC) model of pressure overload-induced hypertrophy, and a swim-induced physiological model of hypertrophy. DDiT4L expression was increased in both the TAC and DCM models (Fig. 1D) but not in the swim model. In contrast, DDiT4 expression was unchanged ( fig. S1C ). Finally, in ventricular tissue from human DCM patients obtained at the time of orthotopic transplantation, the expression of DDiT4L expression, but not that of DDiT4, was increased ( Fig. 1E and fig. S1D ) compared with ageand sex-matched healthy donors. These data show that DDiT4L expression was increased in different models of cardiac pathology in mice and in human DCM patients but was unchanged after physiological stress. Moreover, DDiT4L regulation appeared to be distinct from that of its homolog DDiT4.
In the different cell types of the heart, the expression of DDiT4L was greatest in cardiomyocytes compared to fibroblasts, smooth muscle cells, endothelial cells, and pericytes (Fig. 1F) . In contrast, DDiT4 was expressed at similar amounts between cell types (fig. S1E). Furthermore, DDiT4L expression in NRVMs was unaltered by IGF1 treatment (a model for physiological stress) but increased in response to various pathological stressors, including glucose deprivation, oxidative stress, DNA damage, and pathological stretch (Fig. 1G) . Conversely, DDiT4 was not changed by glucose deprivation or H 2 O 2 treatment but was decreased in the stretch model ( fig. S1F ), further demonstrating the distinct regulation of DDiT4L and DDiT4 expression in NRVMs. These data demonstrated that DDiT4L, but not DDiT4, was selectively expressed in cardiomyocytes and was increased by pathological stress in the heart. DDiT4L inhibits cellular hypertrophy and mTORC1 signaling in NRVMs Given its distinct regulation in both in vivo and in vitro models of pathological stress, we next sought to characterize the role of DDiT4L in cardiomyocytes using small interfering RNA (siRNA)-mediated knockdown and adenoviral-mediated overexpression (Ad-DDiT4L) ( Fig. 2A) . Knockdown of DDiT4L led to a modest but significant increase in cell size, whereas Ad-DDiT4L caused a significant decrease in NRVM size at baseline (Fig. 2B ), suggesting DDiT4L expression is increased in mouse models of pathological hypertrophy and cell models of pathological stress. (A) DSAGE results showed 62 transcripts increased in mice overexpressing SGK-CA, a model of pathological hypertrophy, which were not changed in mice overexpressing Akt-CA or SGK-DN. For each genotype, DSAGE was run on a pool of five mouse heart samples. Parameters were a fold change of at least 1.5, P < 0.001, sense, redundancy greater than 2, and for mice overexpressing Akt-CA or SGK-DN, these transcripts were not increased more than 1.4-fold. (B and C) DDiT4L expression was increased in SGK-CA mouse hearts and in NRVMs infected with SGK-CA virus but not wildtype (WT) mouse hearts or NRVMs infected with myr-Akt virus; n = 3 to 5 mice per genotype, 4 Ad-DDiT4L infections, and 2 dishes per infection. *P < 0.05, ****P < 0.0001 compared to controls, one-way analysis of variance (ANOVA) followed by Bonferroni post test. (D) DDiT4L expression was increased in TAC and genetic DCM but not in an exercise (swim) model of hypertrophy. n = 3 to 5 mice per model. *P < 0.05, **P < 0.01 compared to controls, one-way ANOVA followed by Bonferroni post test. (E) DDiT4L expression was increased in tissue from left ventricles of dilated cardiomyopathy patients at time of explant compared to controls. n = 6 to 8 patients. **P < 0.01, compared to controls, Mann-Whitney nonparametric test. (F) DDiT4L expression was greatest in cardiomyocytes (NRVM) compared to other cell types in the heart. n = 3 preparations and 2 samples per preparation. *P < 0.05, **P < 0.01 compared to cardiomyocytes, one-way ANOVA followed by Bonferroni post test. FB, fibroblast; SMC, smooth muscle cell. (G) DDiT4L expression was increased in models of pathological stress in NRVMs and unchanged in a physiological model [insulin-like growth factor 1 (IGF1) treatment]. n = 3 to 4 preparations and 2 samples per preparation. GF, glucose and serum deprivation. *P < 0.05, **P < 0.01, compared to controls, one-way ANOVA followed by Bonferroni post test.
a possible "antihypertrophic" function for DDiT4L in the absence of external stimuli.
Because DDiT4L inhibits mTOR in other cell types, and because mTOR signaling has been implicated in cardiomyocyte growth (21), we investigated whether DDiT4L inhibited mTOR signaling in NRVMs. siRNA-mediated knockdown of DDiT4L in serum-free conditions (low baseline mTORC1 activity) led to increased mTORC1 activity, as measured by increased phosphorylation of the mTORC1 downstream effector P70 S6 kinase (S6K) at Thr 389 , whereas Ad-DDiT4L led to mTORC1 inhibition, as shown by decreased phosphorylation of S6K (Fig. 2C) . mTORC1 is an important determinant of protein synthesis and cell size in response to both IGF1 (which induces physiological hypertrophy) and phenylephrine (which induces pathological hypertrophy) (22) . Ad-DDiT4L inhibited the increase in NRVM size triggered by treatment with IGF1 ( Fig. 2D ) and attenuated the phenylephrine effect (Fig. 2E) . Together, our results confirmed that DDiT4L inhibited mTORC1 and that increased expression of DDiT4L can partially prevent cardiomyocyte hypertrophy in response to normal and pathological stimuli in NRVMs.
DDiT4L activates autophagy in an mTOR-and TSC2-dependent manner Because mTOR is a central nodal point in the regulation of autophagy, a cellular process that has been implicated in the response of the heart to pathological stressors (23, 24) , we next sought to determine whether DDiT4L activated autophagy in NRVMs. Screening a panel of autophagyrelated genes revealed significant increases in Atg7 and MAPLC3 after Ad-DDiT4L overexpression compared to Ad-GFP (green fluorescent protein) controls, whereas the expression of both genes was decreased after DDiT4L knockdown compared to scramble siRNA controls (Fig. 3A) .
To further study the role of DDiT4L and autophagy, we carried out Western blotting for several components in the mTOR-autophagy pathway. Ad-DDiT4L in NRVMs led to an increase in the microtubuleassociated protein 1A/1B-light chain 3 (LC3II/I) ratio, a marker of functional autophagy (Fig. 3B) , and decreased phosphorylation of Ser 757 in Unc-51-like kinase 1 (Ulk1), a key downstream effector of mTORC1-dependent inhibition of autophagy. The LC3II/I ratio or phosphorylation of Ulk1 was not changed by DDiT4L siRNA in the absence of stimuli; however, DDiT4L knockdown abolished glucose deprivation-induced mTORC1 inhibition ( fig. S2A ) and increased the LC3II/I ratio ( Fig. 3C ), demonstrating that DDiT4L was necessary for glucose deprivationinduced autophagy but might not affect baseline autophagy (in the absence of stress).
To explore whether DDiT4L-induced autophagy was mTORC1-dependent, we treated NRVMs with the mTORC1 inhibitor rapamycin. Independent addition of Ad-DDiT4L or rapamycin inhibited mTORC1 ( fig. S2B ), whereas, together, they increased LC3II/I ratio in a nonadditive manner (Fig. 3D ), suggesting that DDiT4L promotes autophagy through an mTORC1-dependent pathway. We confirmed these findings by cotransfecting a constitutively active form of the mTORC1-activating guanosine triphosphatase Rheb (CA-Rheb) in NRVMs treated with Ad-DDiT4L. Activation of mTORC1 by CA-Rheb led to increased phosphorylation of S6K in Ad-DDiT4L-infected cells and inhibited the increase in the LC3II/I ratio (fig. S2, C to E), demonstrating that DDiT4L acts upstream of mTORC1 in activating autophagy. To further confirm the increase in autophagy indicated by the LC3II/I ratio, confocal microscopy was carried out on NRVMs infected with GFP-LC3-encoding virus. Ad-DDiT4L increased the number of autophagosomes, while DDiT4L knockdown decreased the number of autophagosomes in glucose-deprived cells, but not in rapamycin-treated cells (Fig. 3E ), confirming that DDiT4L played an important role in stimulating autophagy upstream of mTORC1.
To determine whether DDIT4L increased autophagic flux or inhibited lysosomal fusion to autophagosomes in NRVMs, we used bafilomycin, an inhibitor of autophagosome-lysosome fusion. Addition of bafilomycin or Ad-DDiT4L virus alone led to significant increases in the LC3II/I ratio, and the effects of the combination were additive (Fig. 3F) , demonstrating that DDiT4L functioned by increasing autophagic flux. As expected, bafilomycin also caused a significant increase in the abundance of the autophagy adaptor protein p62, although this was not further increased in a significant manner by the addition of AdDDiT4L (Fig. 3F) .
Under many conditions, mTORC1 is activated in a tuberous sclerosis complex 2 (TSC2)-dependent manner; however, mTORC1 activation by amino acids is TSC2-independent (25, 26). To determine whether DDiT4L-mediated autophagy was TSC2-dependent, we measured autophagy in NRVMs with TSC2 knockdown. Ad-DDiT4L did not induce autophagy or alter the phosphorylation of Ulk1 or S6K in NRVMs with TSC2 knockdown (Fig. 3G ). These findings suggested that in NRVMs, DDiT4L induces autophagic flux in an mTORC1-and TSC2-dependent manner.
DDiT4L is localized to early endosomes and may interact with mTOR DDiT4L binds to interferon regulatory factor 1 in a punctate pattern in the cytoplasm of bone marrow cells (27) . In NRVMs infected with Ad-DDiT4L, immunoreactivity for DDiT4L was found in the cytoplasmic but not in the nuclear fractions (Fig. 4A) . Because of the lack of DDiT4L antibodies that are reliable for immunocytochemistry, we performed hemagglutinin (HA) immunostaining in Ad-DDiT4L-infected, serum-starved NRVMs and found that HA-tagged DDiT4L was present in a punctate pattern in the cytoplasm (Fig. 4B and fig.  S2F ). HA-tagged DDiT4L did not localize with the lysosomal protein Lamp1, the autophagosomal protein LC3, the vesicular protein Vamp4, the lipid raft protein caveolin 3, the endosomal protein Appl, the Golgiassociated protein GOPC, or the vesicular protein syntaxin 3 ( fig. S2F ) under serum-free conditions. However, HA-tagged DDiT4L partially localized with EEA1 (early endosome antigen 1) and Rab5 under these conditions, indicating that DDiT4L could be found in early endosomes (Fig. 4B ). Under these conditions, DDiT4L also appeared to localize with mTOR, suggesting that trafficking of DDiT4L in early endosomes to compartments where mTOR is present could occur. HA-tagged DDiT4L also coimmunoprecipitated with mTOR under mild detergent conditions, suggesting the presence of DDiT4L in a complex that also contains mTOR ( fig. S2G ). These data showed that in NRVMs, DDiT4L was localized on early endosomes and could exert its effect on autophagy by inhibiting mTOR, although the other components of this complex are yet to be elucidated.
DDiT4L expression is increased by SRF
DDiT4 is the target of the hypoxia-inducible transcription factor HIF1a (28, 29) . Analysis of the 5′ untranslated region (5′UTR) of DDiT4L revealed a putative cArG box-like serum response element, suggesting possible binding by SRF, a transcription factor that is stimulated by pathological stress in the heart (30, 31) . Luciferase assays using a plasmid containing the 2000-base pair (bp) upstream region of DDiT4L in human embryonic kidney (HEK) 293 cells demonstrated that SRF cotransfection increased luciferase activity, which was not seen when the cArG box was mutated (Fig. 4C) . In NRVMs, glucose deprivation or infection with SGK1-CA adenovirus increased the activity of SRF, as indicated by the increased phosphorylation of Ser 103 (Fig. 4D) , which was associated with increased DDiT4L mRNA expression under these conditions (Fig. 1, B and G) . Furthermore, silencing of SRF in NRVMs abolished the increase in DDiT4L expression induced by SGK1-CA adenovirus or glucose deprivation (Fig. 4E) . These findings showed that SRF was necessary and sufficient to induce DDiT4L in response to certain stressors and links cellular stress to autophagy and mTORC1 signaling through DDiT4L.
Overexpression of DDiT4L in the heart leads to increased autophagy and mild systolic dysfunction that is reversed by suppressing transgene expression We next sought to investigate DDiT4L in vivo by conditionally overexpressing DDiT4L in cardiomyocytes using an a-MHC tet-off system knockdown. n = 4 preparations and 2 samples per preparation. *P < 0.05, ***P < 0.001 compared to control, one-way ANOVA followed by Bonferroni post test. Phosphoproteins were normalized to total protein. (C) Glucose deprivation (−GLU) increased autophagy, which was inhibited by DDiT4L knockdown. n = 3 preparations and 2 samples per preparation. *P < 0.05, **P < 0.01 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. (D) Treatment of Ad-DDiT4L-infected cells with rapamycin did not lead to a further increase in autophagy. n = 4 preparations and 2 samples per preparation. *P < 0.05, ***P < 0.001 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. (E) Glucose deprivation, rapamycin, and Ad-DDiT4L infection increased the number of GFP-LC3 autophagosomes in NRVMs, and knockdown of DDiT4L prevented the increase caused by glucose deprivation. n = 4 preparations, 2 samples per preparation, 4 images per coverslip, and 100 to 160 cells per treatment. Arrows indicate cells with autophagosomes. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. (F) Ad-DDiT4L infection and bafilomycin increased the LC3II/I ratio in an additive fashion. n = 6 to 10 preparations and 2 samples per preparation. Bafilomycin treatment, but not Ad-DDiT4L infection alone, significantly increased p62 abundance. n = 4 preparations and 2 samples per preparation. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. (G) TSC2 knockdown attenuated the induction of autophagy by Ad-DDiT4L infection in NRVMs, as assessed by LC3II/I or phosphorylation of Ser 757 in Ulk1, and inhibited the decrease in pS6K. n = 4 preparations and 2 samples per preparation. *P < 0.05 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. Phosphoproteins were normalized to total protein.
( fig. S3A ) (32) . When mated with the tetracycline-activator driver (tTA), transgene expression is suppressed by doxycycline in the "double transgenic" mice (referred to as DDiT4L/tTA) and activated by removal of doxycycline from the diets of these mice ( fig. S3A ). DDIT4L was increased in abundance in the heart (Fig. 5A ) to amounts similar to that seen after TAC-induced hypertrophy ( fig. S3B ), but not at the mRNA level in quadriceps muscle or lung ( fig. S3C ). As expected from our NRVM experiments, DDiT4L overexpression triggered an increase in autophagy and a decrease in mTOR signaling (Fig. 5, A to F ). There were no compensatory changes in DDiT4 in the DDiT4L/tTA mice ( fig. S3D ).
Mice with overexpression of DDiT4L from birth (because doxycycline was not added to their diet after birth) showed mild ventricular remodeling, mild left ventricular dilation, and decreased fractional shortening and wall thickness on echocardiography (Fig. 5 , G to I) but no changes in heart weight-to-body weight ratio (HW/BW) or heart weight-to-tibia length ratio (HW/TL) at 5 months of age (table  S2) . The DDiT4L/tTA mice had no changes in myocyte architecture or in cross-sectional cell size, as measured by hematoxylin and eosin staining and wheat germ agglutinin (WGA) staining of cardiac tissue sections, respectively ( fig. S3E ), but the length of isolated ventricular cells was decreased compared to cells from tTA controls (fig. S3G ). DDiT4L/tTA mouse sarcomeres were not disorganized but were shorter when compared with tTA mouse (fig. S3H ). The decrease in the wall thickness, cardiomyocyte length, and sarcomere length suggests a mild antihypertrophic effect of DDiT4L in the heart at baseline (33, 34) . of DDiT4L cloned into Bgl basic luciferase construct. SRF-like cARG box is highlighted in red, and the DDiT4L start codon is highlighted in blue. HEK293 cells transfected with SRF plasmid and the 5′UTR luciferase construct had increased luciferase activity, which was not seen when the cArG box was mutated to CCGGGGAAGCGC. n = 5 preparations and 2 samples per preparation. ***P < 0.01, one-way ANOVA followed by Bonferroni post test. (D) Glucose deprivation or infection with SGK-CA adenovirus increased phosphorylation of SRF in NRVMs. n = 4 to 5 preparations and 2 samples per preparation. *P < 0.05, **P < 0.01 compared to control, Student's t test. Phosphoproteins were normalized to total protein. (E) Knockdown (KD) of SRF in NRVMs prevented SGK-CA adenovirus and glucose deprivation from inducing increased expression of DDiT4L. n = 4 preparations and 2 samples per preparation. *P < 0.05, **P < 0.01, one-way ANOVA followed by Bonferroni post test. , and no changes in p62 abundance (F). These effects were reversed upon transgene suppression. n = 6 to 9 mice per genotype. *P < 0.05, **P < 0.01, ****P < 0.0001, one-way ANOVA followed by Bonferroni post test. Representative Western blots are from the same blot, but they may not be contiguous. Phosphoproteins were normalized to total protein. Dox, doxycycline. (G to I) Mice overexpressing DDiT4L from birth show decreased fractional shortening (FS) (G), thinner ventricular walls (H), and a larger left ventricular internal diastolic dimension (LViDd) (I), which was reversed upon doxycycline administration. n = 6 to 9 mice per genotype. *P < 0.05 compared to tTA control, # P < 0.05 compared to DDiT4L/tTA, two-way ANOVA followed by Bonferroni post test. (J) ANP expression was increased and the a/b-MHC ratio and Cited4 expression was decreased in mice overexpressing DDiT4L, which was reversed by transgene suppression. n = 6 to 9 mice per genotype. *P < 0.05 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. (K) EM images showed increased numbers of autophagosomes (indicated by the arrows) in cardiomyocytes from DDiT4L-overexpressing mice. n = 4 mice per genotype. Scale bars, 5 mm.
There was no increase in macroscopic fibrosis in the DDiT4L/tTA mice, but these mice had an increase in the expression of Col1, Col3, and CTGF, which encode the profibrotic factors collagen 1, collagen 3, and connective tissue growth factor, respectively ( fig. S3F ). These mice also had increased ANP (which encodes atrial natriuretic peptide), decreased a/b-MHC ratio, and decreased Cited4 expression (Fig. 5J ) (35) , suggestive of a fetal gene expression program seen under pathological stress. Consistent with its effects on autophagy and mTORC1 signaling in vitro, the transgenic mice had decreased phosphorylation of S6K (Fig.  5 , A and C) and increased autophagy, as shown by an increase in the LC3II/I ratio (Fig. 5, A and D) , decreased phosphorylation of Ulk1 (Fig.  5, A and E) , no change in p62 abundance (Fig. 5, A and F) , and increased numbers of autophagosomes by electron microscopy (EM) imaging (Fig. 5K) . Together, these data confirmed that DDiT4L expression in cardiomyocytes inhibited mTORC1 and induced autophagy in vivo. Furthermore, it appeared that induction of stress-autophagy pathways at baseline led to a mild ventricular dysfunctional phenotype. When we fed doxycycline to these mice at 3 months of age to suppress the overexpression of the transgene, DDiT4L abundance returned to baseline (Fig. 5, A and B), and cardiac structure and function normalized (Fig.  5, G to I ). There was a concomitant normalization of the expression of pathological and fibrosis genes (Fig. 5J and  fig. S3F ), derepression of mTORC1 signaling, and normalization of autophagy (Fig. 5 , A to F and K), suggesting that the phenotype observed was the direct effect of DDiT4L signaling and not a secondary effect due to developmental changes or adaptive changes in response to the cardiac structural phenotype.
Transgenes under the a-MHC promoter are not substantially expressed prenatally. However, to confirm that the effects were not due to developmental overexpression of DDiT4L, we kept the pups and their mother on a doxycycline diet to suppress transgene expression until 1 month after birth and then switched the mice to normal chow to allow transgene expression. Echocardiography was performed before cessation of doxycycline and at 1 and 2 months after transgene expression. DDiT4L-overexpressing mice showed no changes in their heart function after 1 month of normal chow compared to tTA controls, but after 2 months, they developed a cardiac phenotype similar to the mice with DDiT4L overexpression in the heart for 5 months, as described above ( fig.  S4 , A to C). Moreover, 1 month after normal chow, there was decreased phosphorylation of S6K ( fig. S4, D and E) , increased LC3II/I ratio ( fig. S4, D and F) , and decreased p62 abundance ( fig. S4, D and H) . These results suggested that inhibited mTORC1 and increased autophagic flux induced by DDiT4L overexpression preceded and was likely responsible for the cardiac structural and functional changes in these mice. Our data suggested that overexpression of DDiT4L at baseline led to mTORC1 inhibition and an increase in autophagic flux, which resulted in mild ventricular dysfunction characterized by cardiac atrophy and a pathological molecular signature, all of which were reversed by suppression of the transgene.
Heterozygous knockout of beclin partially reverses the effect of DDiT4L/tTA overexpression in the heart To discriminate the specific role of autophagy from the overall effect of inhibited mTORC1 signaling on the cardiac phenotype, DDiT4L/tTA mice were crossed with beclin 1 +/− knockout mice, in which autophagy is decreased downstream of mTORC1 signaling (36, 37) . As expected, phosphorylation of S6K was decreased in these mice at 2 months of age, consistent with continued mTORC1 inhibition (Fig. 6, A and B) . However, the increase in autophagy in the DDiT4L/tTA mice was normalized as assessed by the LC3II/I ratio (Fig. 6C) , which was associated with a normalization of the cardiac phenotype, notably a reversal of the effect of DDiT4L/tTA on cardiac fractional shortening Fig. 6 . Heterozygous knockout of beclin partially reverses the effect of DDiT4L/tTA overexpression in the heart. (A to C) Western blots (A) of cardiac lysates showed that DDiT4L/tTA/Beclin (Bec) mice had no change in the phosphorylation of Thr 389 in S6K (B) but normalized LC3II/I ratios (C) compared to DDiT4L/tTA mice at 2 months. n = 3 to 6 mice per genotype. *P < 0.05 compared to control, oneway ANOVA followed by Bonferroni post test. Phosphoproteins were normalized to total protein. (D to F) DDiT4L/tTA/Beclin mice had heart function comparable to tTA controls, with a significant difference in fractional shortening compared to DDiT4L/tTA mice. n = 3 to 6 mice per genotype. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. (G) DDiT4L/tTA/Beclin mice had normalized ANP and Cited4 expression compared to DDiT4L/tTA transgenic mice. n = 3 to 6 mice per genotype. *P < 0.05 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. n.s., not significant. (Fig. 6D) , left ventricular internal diastolic dimension (Fig. 6E) , and wall thickness (Fig. 6F) . Finally, the suppression of autophagy also correlated with a reversal of the pathological molecular signature induced by DDiT4L overexpression (Fig. 6G) . Overall, our results suggest that the baseline increase in stress autophagy in the DDiT4L/tTA mice has a detrimental but reversible effect on cardiac structure and function.
DDiT4L increases phosphorylation of Akt at Ser 473
The DDiT4L/tTA mice have a relatively mild phenotype compared to murine models with mTOR ablation, which results in the inhibition of both mTORC1 and mTORC2 (38) . We therefore investigated the possibility that mTORC2 may be activated as a compensatory mechanism, thereby mitigating some of the deleterious effects of mTORC1 inhibition at baseline (5, 7). Phosphorylation of Akt (also known as protein kinase B) at Ser 473 is a downstream marker of mTORC2 activity and was increased with cardiac overexpression of DDiT4L at 5 months (Fig. 7A) , although the increase was not significant at 1 month of transgene expression ( fig. S4G) . As with the other cardiac phenotypes described above, this increase was also reversed by transgene suppression (Fig. 7A) , but not by suppression of autophagy in the DDiT4L/ tTA/Beclin mice (Fig. 7B) . These data suggested that Akt phosphorylation was more likely related to DDiT4L-mediated effects on mTOR signaling rather than to a secondary response to the cardiac dysfunction. Correspondingly, phosphorylation of Akt in NRVMs was Fig. 7 . DDiT4L activates Akt. (A) Phosphorylation of Akt was increased in DDiT4L-overexpressing mice, which was reversed after transgene suppression. n = 6 to 9 mice per genotype. *P < 0.05, one-way ANOVA followed by Bonferroni post test. Phosphoproteins were normalized to total protein. (B) Phosphorylation of Akt remained increased in DDiT4L/tTA/Beclin mice. n = 3 to 6 mice per genotype. *P < 0.05, one-way ANOVA followed by Bonferroni post test. Phosphoproteins were normalized to total protein. (C) Phosphorylation of Akt was increased in NRVMs infected with Ad-DDiT4L, with no change seen with DDiT4L knockdown. n = 4 to 6 preparations and 2 samples per preparation. *P < 0.05 compared to control, one-way ANOVA followed by Bonferroni post test. Phosphoproteins were normalized to total protein. (D) Knockdown of Rictor reduced Ad-DDiT4L infection from increasing the phosphorylation of Akt. n = 4 preparations and 2 samples per preparation. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. Ad-C, Ad-Control. (E) Phosphorylation of Akt was increased in Ad-DDiT4L-infected NRVMs, which was blunted after knockdown of TSC2. n = 4 preparations and 2 samples per preparation. ***P < 0.001, ****P < 0.0001 compared to control or indicated sample, one-way ANVOA followed by Bonferroni post test. Phosphoproteins were normalized to total protein. (F) Knockdown of Raptor increased phosphorylation of Akt, which was not further increased with Ad-DDiT4L infection. n = 3 preparations and 2 samples per preparation. *P < 0.05, ***P < 0.001 compared to control or indicated sample, one-way ANOVA followed by Bonferroni post test. Phosphoproteins were normalized to total protein.
increased by Ad-DDiT4L infection but unaffected by DDiT4L knockdown (Fig. 7C) .
The phosphorylation of Thr 1179 in insulin receptor substrate 1 (IRS1) was not altered in the hearts of DDiT4L-overexpressing mice or in Ad-DDiT4L-infected NRVMs ( fig. S5, A and B) . Because this phosphorylation event is required for downstream phosphoinositide 3-kinase (PI3K)-mediated phosphorylation of Akt (39) , this finding suggested that the increase in the phosphorylation of Akt was not secondary to upstream activation of the IGF/PI3K pathways ( fig. S5, A and B) . Finally, silencing of Rictor in NRVMs abrogated the increase in the phosphorylation of Akt with Ad-DDiT4L infection (Fig. 7D) , providing further evidence that the activation of Akt with DDiT4L overexpression depended on the presence of the mTORC2 complex. Together, these data suggested that DDiT4L overexpression led to mTORC2 activation. DDiT4L overexpression did not induce an increase in the phosphorylation of Akt in NRVMs with knockdown of TSC2 (Fig. 7E) , suggesting that, similar to DDiT4L-mediated inhibition of mTORC1, the activation of mTORC2 with DDiT4L overexpression was TSC2-dependent. siRNA-mediated ablation of raptor in NRVMs led to increased basal phosphorylation of Akt (Fig. 7F) , which was not further augmented by Ad-DDiT4L infection, showing that the DDiT4L-mediated increase in mTORC2 activity proceeded through mTORC1 inhibition. These data are consistent with the inhibition of mTORC2 by mTORC1-mediated phosphorylation of the stress-activated protein kinase sin1 (40) . DDiT4L inhibition of mTORC1 may subsequently derepress this axis, representing another facet of the complex interplay between mTORC1 and mTORC2 signaling.
DISCUSSION
Autophagy in the heart plays a critical role both in normal homeostasis and in the response to stressors. Here, we characterized DDiT4L, a regulator of mTOR signaling in the heart that was identified in a discovery screen to delineate signaling pathways that were differentially activated by pathological and physiological stress. We showed that DDiT4L activated stress-induced autophagy and differentially regulated mTORC1 and mTORC2 signaling in cardiomyocytes in a TSC2-dependent mechanism. Expression of DDiT4L in the heart increased basal autophagy and caused mild dysfunction, mild atrophy, and a molecular signature of pathological stress. This phenotype was completely reversed by suppression of DDiT4L expression and by genetic suppression of autophagy, raising the possibility of therapeutic targeting of DDiT4L in cardiomyopathies.
This study stemmed from a DSAGE-based discovery, which identified DDiT4L as the top candidate gene that showed increased expression specifically in a transgenic model of pathological hypertrophy, but not in a transgenic model of physiological hypertrophy. DDiT4L expression was also increased in other genetic and acquired murine and cultured cardiomyocyte models of pathological stress, but not in physiological stress, and was increased in the left ventricle of human DCM patients. We observed increases in DDiT4L mRNA in TAC after 1 week during the hypertrophy phase and in the DCM mouse model, which have dilated ventricles and abnormal wall stress. The temporal expression of DDiT4L in mice subjected to TAC as they progress from hypertrophy to heart failure may be complex and subjected to multiple different interacting signaling pathways. In this regard, regulation of autophagy is complex in the TAC model, with initial increases in autophagy followed by a suppression of autophagy in the chronic heart failure stages (41) . In cardiomyocytes, DDiT4L expression was increased by the transcription factor SRF, which has previously been implicated in mediating stress responses in the heart (42, 43) . Knockdown of DDiT4L at baseline in cardiomyocytes led to activated mTORC1 but not to changes in autophagy signaling, suggesting that SRF increases DDiT4L expression under stress conditions and may specifically regulate stressinduced autophagy rather than basal autophagy.
DDiT4L protein localized with both early endosome markers and mTOR under stress conditions when DDiT4L is activated and mTOR is inhibited, suggesting that DDiT4L may traffic to an mTOR-containing cellular compartment when cells are under stress, leading to inhibition of mTORC1 through a TSC2-dependent manner. However, the interaction between DDiT4L and the mTOR complex in this cellular compartment and the exact mechanism of interaction are yet to be elucidated. In the absence of stressors, a basal increase in DDiT4L in the heart increased autophagy, led to a mild reversible cardiomyopathy with mild cardiac atrophy, and inhibited cardiomyocyte growth. These effects were not observed when autophagy was genetically inhibited in these mice, demonstrating that it was due to increased autophagy rather than to overall inhibition of mTORC1. Whether these antihypertrophic effects of DDiT4L are adaptive or additionally maladaptive in the presence of pathological stressors will be the subject of future investigations in murine models of heart disease.
In both cultured cardiomyocytes and the DDiT4L transgenic mouse, we saw increased autophagy, measured through Western blotting for LC3II/I and phosphorylated Ulk1 and through confocal and EM imaging. Through treatment of cardiomyocytes with bafilomycin and measuring LC3II/I and p62, we concluded that this was due to increased autophagic flux rather than to inhibited lysosomal fusion. Although the abundance of p62 was unchanged (at 5 months) or slightly decreased (1 month) in the transgenic mouse model, this was not surprising because p62 undergoes complex transcriptional regulation over time, altering protein abundance independently of autophagy (44) (45) (46) . There is a distinction between classic (mediated through atg5/atg7) and alternative (mediated through Ulk/beclin/rab9) pathways (47, 48) . Given the implication of Ulk-1 and beclin in DDiT4L-induced autophagy, it is possible that DdiT4L may couple cellular stress to the alternative autophagy pathway. However, further complementation experiments with critical components of these pathways would be necessary to fully delineate these mechanisms.
Fully reversible cardiac phenotypes are rare and can shed light on pathways that may be targeted for therapeutic development for heart disease. Our DDiT4L transgenic mouse had complete reversal of both the cardiac phenotype and the molecular signature of DDiT4L overexpression with inhibition of transgene expression and when autophagy was inhibited through beclin 1 haploinsufficiency, confirming that the reversible nature of this phenotype was due to autophagy. It is possible that the reversal of this phenotype has to occur within a certain time window, and prolonged periods of increased baseline autophagy may ultimately lead to irreversible changes. Another mouse model of increased autophagy and cardiomyocyte atrophy shares features with our model, demonstrating similar reversibility upon cessation of transgene expression (34) . These findings highlight the importance of autophagy in basal and disease conditions in the heart and put forward DDiT4L and autophagy as therapeutic targets for heart disease.
We postulate that the mild phenotype observed in our mouse model (compared to ablation of models of mTOR ablation) was due to the counteracting protective role for mTORC2 signaling. We found a significant increase in the phosphorylation of the specific mTORC2 target Ser 473 in Akt in our transgenic mouse model and in NRVMs overexpressing DDiT4L. Phosphorylation of Akt at Ser 473 is typically seen in physiological models of cardiac hypertrophy (49, 50) and acute overexpression of active Akt prevents progression to heart failure in mice that have undergone pressure overload-induced hypertrophy (51), suggesting one possible mechanism for cardioprotection by DDiT4L overexpression. This activation of Akt was not due to increased autophagy because the DDiT4L/tTA/Beclin mice still showed increased phosphorylation of Akt despite decreased autophagy. DDiT4L modulation of both mTORC1 and mTORC2 pathways adds another facet to a complex feedback regulatory pathway where the exact balance between mTORC1 and mTORC2 activity may ultimately determine the cardiac phenotype.
Finally, our studies showed that, unlike DDiT4, DDiT4L may be implicated more in stress responses than in basal ones. Unlike DDiT4, the DDiT4L protein structure has not been solved, and apart from its binding to 14-3-3, little is known about its functional domains. The crystal structure of DDiT4 has revealed a conserved functionally important hotspot, which prevents DDiT4 from inhibiting mTOR when mutated (52) . This conserved site is not present on DDiT4L, suggesting that DDiT4L inhibits mTOR through other binding partners. Furthermore, mTORC1 activation depends on DDIT4 translocation to the plasma membrane mediated by heterotrimeric guanine nucleotidebinding protein-coupled receptors, and this translocation was not observed with DDiT4L (53) .
In summary, our current model demonstrated that DDiT4L was activated by pathological stress in the heart by SRF, leading to induction of autophagy through inhibition of mTORC1 signaling. In addition, DDiT4L led to activation of mTORC2. Overexpression of DDiT4L in the heart in vivo resulted in increased autophagy, inhibited mTORC1, activated mTORC2, increased markers of pathological hypertrophy, and mild functional and structural changes. This phenotype was completely reversed by the suppression of transgene expression or genetic inhibition of autophagy. Because of the importance of autophagy and mTOR signaling in the heart and disease, further investigation into DDiT4L and its regulation of autophagy and mTOR may lead to novel therapeutic targets for treatment of heart pathologies.
MATERIALS AND METHODS
Generation of adenovirus HA-DDiT4L adenovirus was generated with the AdEasy system following published protocols (54), infected into HEK293T cells, and isolated using Vivapure AdenoPACK (Sartorius Stedim Biotech). Exercise model of physiological hypertrophy Mice aged 12 to 16 weeks were forced to swim in a tank (diameter, 50 cm; surface area,~2000 cm 2 ) containing water maintained at 30°to 32°C to avoid thermal stress. Mice initially swam for 10 min twice per day, with the sessions separated by a 4-hour break. The swim sessions were increased by 10 min each day until the sessions reached a maximum of 90 min each, which were maintained for the remainder of the program. The mice swam 7 days/week for 4 weeks to produce a robust cardiac hypertrophic response (10% increase in HW/BW).
TAC model
Mice aged 8 to 12 weeks were anesthetized either with ketamine (80 to 100 mg/kg) and xylazine (12 mg/kg) or with inhaled isofluorane (1 to 2% isofluorane in oxygen, dosed to effect). Mice were intubated using a 22GA Angiocath and placed on a small animal ventilator (CWE), and anesthesia with 1 to 2% isofluorane in oxygen was delivered through the ventilator. Ventilation parameters were as follows: tidal volume, 0.25 ml; respiratory rate, 110 breaths/min; inspiratory time, 0.3 s. The operative field was shaved and cleaned with 10% Betadine and 70% EtOH. A lateral thoracotomy was performed with hemostasis achieved using the Gemini microcautery system. The ascending aorta was dissected from the surrounding connective tissue, and a 6.0 silk Prolene suture without needle was placed around the transverse aorta. The suture was then tied down against a blunted 25-gauge needle, and the needle was removed to create a chronic model of pressure overload hypertrophy. The chest cavity was closed using a continuous silk 6.0 Prolene suture and 9-mm wound clips. The animal was maintained on a warm pad throughout the procedure and kept on the pad until recovery from anesthesia. Once regular spontaneous respirations resumed, the mouse was disconnected from the ventilator and extubated. The animal was observed until it could ambulate and then transferred back to a new cage. Wound clips were removed 10 days postoperatively, and animals received buprenorphine for 3 days after getting the first dose preemptively.
DSAGE screen
RNA was extracted from transgenic mice with cardiac-specific overexpression of SGK1-CA and SGK1-DN mice (17) as well as from transgenic mice with cardiac-specific overexpression of Akt1-CA (18) and Akt1-DN (19) mice. Total RNA was prepared from five hearts of male mice of each genotype at 4 weeks using TRIzol (Invitrogen). RNA from each genotype was pooled in equal proportion to provide 10 mg of total RNA for the generation of cDNA libraries (16, 55) and subjected to DSAGE, as previously described (16, 55) . For DSAGE results, statistical comparisons of gene expression were performed as previously described (56) using the Audic and Claverie alternative to Fisher's exact test (16, 49, 57) .
Human studies
Discarded, deidentified (anonymized) pathological tissues were obtained and studied under an institutional review board-approved protocol.
Cardiac function
Echocardiograms were performed on anesthetized mice using a GE Vivid 7 ultrasound machine (GE Healthcare) with a frequency of 14.0 mHz, 131.5 frames/s, and a depth of 1 cm for two-dimensional images. M-mode images were taken at the midpapillary muscle level and were used for measurements. Echocardiograms were analyzed using Vivid 7 software.
Tissue harvesting
Mice were sacrificed by overdose of ketamine (80 mg/kg)/xylazine (12 mg/kg). Body weight, dry lung, heart, and left ventricular weight were measured along with tibia length. The left ventricle was cut into three pieces for RNA extraction, protein extraction, and immunohistochemistry.
Immunohistochemistry
Cardiac slices stored in 4% paraformaldehyde (PFA) were embedded in paraffin, sectioned, and stained with Masson's trichrome stain (for fibrosis), hematoxylin and eosin (for histology), and WGA (for cell size) (BIDMC Histology Core). Slides were imaged on either an upright fluorescent microscope (Leica CTR5000) or a Zeiss confocal microscope (LSM 510 Meta), and cell size was measured using ImageJ software. Isolation and culture of neonatal rat ventricular cardiomyocytes and other primary cells NRVMs and fibroblasts were isolated from postnatal day 1 rat pups using enzymatic digestion. Twenty-four hours after plating, medium was changed to a serum-and antibiotic-free one, and after 24 hours, cells were transfected with DDiT4L siRNA (Qiagen), TSC2 GapmeR antisense oligonucleotide (Exiqon), and/or CA-Rheb plasmid [Addgene # 32520 (58)] or infected with HA-DDiT4L adenovirus or GFP-LC3 adenovirus (gift from J. Sadoshima, Rutgers, NJ). Forty-eight hours after transfection or infection, cells were used for experiments. The smooth muscle cell line pac1 was purchased from American Type Culture Collection. Endothelial cells and pericytes were isolated from mouse hearts and skeletal muscle using Dynabeads (59, 60) . The following treatments were carried out: glucose deprivation (for 2 hours), oxidative stress (100 mM H 2 O 2 for 18 hours), pathological stretch (20% stretch over 6 hours), DNA damage (2.5 mM doxorubicin for 6 hours), IGF1 (20 ng/ml for 24 hours), phenylephrine (10 mM for 24 hours), rapamycin [10 nM for 2 hours; high dose (50 nM) for 2 hours], and bafilomycin (20 nM for 6 hours).
Electron microscopy
Real-time PCR RNA was isolated from both tissue and cell samples using TRIzol (Qiagen), and phase separation followed by column purification (Qiagen). RNA (1 mg) was added to real-time PCRs (Applied Bioscience), and qPCR was carried out using SYBR Green (Kapa). Primers used are listed in tables S3 and S4.
Western blotting
Protein lysates from both tissue and cells were made using lysis buffer (Cell Signaling) containing phenylmethylsulfonyl fluoride, protease, and phosphatase inhibitors for 1 hour at 4°C with shaking. Protein (50 mg) was run on a 4 to 11% SDS-polyacrylamide gel electrophoresis gel (Criterion, Bio-Rad), transferred onto nitrocellulose, blocked in 5% bovine serum albumin or milk, and probed with the following primary antibodies: DDiT4L (Fitzgerald); DDiT4L (Abcam); P-S6K, S6K, LC3II/I, HA, P-Ulk1,Ulk1, Histone H3, P-Akt, and Akt (Cell Signaling); GAPDH, TSC2, SRF, and IRS1 (Santa Cruz Biotechnology); and P-SRF and P-IRS1 (Abcam). Proteins were detected using an anti-goat secondary antibody conjugated to horseradish peroxidase (Dako) and a Bio-Rad ChemiDoc MP. Blots were analyzed using ImageJ software, with proteins normalized to the housekeeper GAPDH and phosphoproteins normalized to their respective total protein.
Confocal microscopy
Cells were plated on 15-mm laminin-coated coverslips and treated as previously described, fixed, stained, and imaged on a Zeiss 710 confocal microscope. For autophagasome experiments, cells were infected with GFP-LC3 virus 48 hours before fixation. Cells were fixed with 4% PFA for 20 min, permeabilized for 20 min with 0.5% Triton X-100, stained with a-actinin (Abcam), mounted using DAPI HardSet Mounting Media (Vector Laboratories), and imaged using a Zeiss 710 confocal microscope. For localization experiments, the following antibodies were used at a concentration of 1:100: HA, LC3II/I, mTOR, caveolin 3, Appl, GOPC, Syntaxin6 (Cell Signaling), LAMP1 (Abgent), and VAMP4 (Novus Biologicals). Image analysis was carried out using ImageJ software.
Luciferase assay A luciferase reporter plasmid was made by inserting about 2100 bp of the 5′UTR of mouse DDiT4L into a pGL3 basic luciferase reporter vector. Luciferase assays were carried out using Promega Dual Luciferase Assay kits. SRF plasmid was purchased from Addgene. mTOR immunoprecipitation mTOR immunoprecipitations were carried out using 0.3% CHAPS, as previously described (61).
Statistics
Unless otherwise specified, data are expressed as means ± SEM. All statistics were carried out using GraphPad Prism 5. Mean comparisons between two groups were compared using the unpaired Student's t test. For multiple comparisons, one-or two-way ANOVAs were performed, followed by Bonferroni post test, as specified. For data that were not normally distributed, nonparametric testing was carried out, as indicated in the figure legends.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/10/468/eaaf5967/DC1 Fig. S1 . DDiT4 is differentially regulated compared to DDiT4L. Fig. S2 . Regulation of mTOR signaling by DDiT4L under different conditions in NRVMs. Fig. S3 . Conditional heart-specific overexpression of DDiT4L. Fig. S4 . Acute increases in DDiT4L lead to alterations in mTORC1 signaling but not in systolic function. Fig. S5 . Overexpression of DDiT4L does not alter the phosphorylation of IRS1. Table S1 . Top 20 candidates from DSAGE screen of genes with increased expression in SGK-CA mice compared to other transgenic mice. Table S2 . DDiT4L/tTA mice have mild diastolic dysfunction, which is reversed upon transgene suppression Table S3 . Mouse primers. Table S4 . Rat primers. Data file S1. Raw DSAGE data file.
